Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

mylan, lda. - valganciclovir - comprimido revestido por película - 450 mg - valganciclovir, cloridrato 496.3 mg - valganciclovir - genérico - duração do tratamento: longa duração

Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

mylan, lda. - valganciclovir - comprimido revestido por película - 450 mg - valganciclovir, cloridrato 496.3 mg - valganciclovir - genérico - duração do tratamento: longa duração

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - valganciclovir, quantity: 450 mg - tablet, film coated - excipient ingredients: povidone; stearic acid; microcrystalline cellulose; crospovidone; titanium dioxide; hypromellose; polysorbate 80; iron oxide red; macrogol 400 - valganciclovir is indicated for the treatment of cytomegalovirus (cmv) retinitis in patients with acquired immunodeficiency syndrome (aids). valganciclovir is indicated for the prophylaxis of cmv infection and disease following solid organ transplantation in patients at risk of cmv disease.

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

mylan s.a.s., saint priest, france (0000008105) 117 allee des pares, 69800, saint priest - valganciclovir hydrochloride - ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - 450mg/tab - ineof01485 valganciclovir hydrochloride 496.300000 mg - valganciclovir

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

mylan pharmaceuticals, s.l. - valganciclovir - excipientes: polisorbato 80 - antivirales de acciÓn directa - nucleosidos y nucleotidos, excluyendo inhibidores de la transcriptasa inversa - valganciclovir

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

apotex europe b.v. - valganciclovir - excipientes: xantano, goma de - antivirales de acciÓn directa - nucleosidos y nucleotidos, excluyendo inhibidores de la transcriptasa inversa - valganciclovir

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - ganciclovir sodium, quantity: 546 mg (equivalent: ganciclovir, qty 500 mg) - injection, powder for - excipient ingredients: - ganciclovir sxp (ganciclovir) administered as the iv infusion is indicated for the palliative treatment of confirmed sight-threatening cytomegalovirus (cmv) disease in aids and other severely immunocompromised individuals. it is indicated for the treatment of confirmed cmv pneumonitis in bone marrow transplant patients. it is also indicated for the prophylaxis of cmv infection and disease following bone marrow and solid organ transplantation in patients at risk of cmv disease.,note: ganciclovir sxp (ganciclovir) is not indicated for congenital or neonatal cmv disease; nor for the treatment of cmv infection in non-immunocompromised individuals.

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - valganciclovirum - compresse rivestite con film - valganciclovirum 450 mg ut valgancicloviri hydrochloridum 496.3 mg, cellulosum microcristallinum, mannitolum, magnesii stearas, silica colloidalis anhydrica, crospovidonum, Überzug: hypromellosum, lactosum monohydricum 6.7 mg, triacetinum, e 171, e 172 (rubrum), pro compresso obducto. - virostaticum - synthetika

Moldova - rumensk - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

belmedpreparatî rup - ganciclovirum - pulbere liofilizată pentru soluţie perfuzabilă - 500 mg

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - valganciclovirum - compresse rivestite con film - valganciclovirum 450 mg per valgancicloviri hydrochloridum, cellulosum microcristallinum, crospovidonum, povidonum k 30, acido stearicum, Überzug: hypromellosum, e 171, macrogolum 400, e 172 (rosso), polysorbatum 80, per compresso haze. - virostatikum - synthetika